• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of International Child Neurology Association

    Journal of International Child Neurology Association

    Journal

    年发文量

    研究主题

    论文(24)

    排序
    1Paediatric Acquired Demyelinating Syndromes
    Ori Haddad,Yael Hacohen,Omar Abdel-Mannan

    Paediatric acquired demyelinating syndromes (ADS) are characterised by neurological deficits persisting for at least 24 hours, involving the optic nerve, spinal cord or brain with a clinical spectrum of diagnoses including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and MOG-Ab associated disease (MOGAD). Important strides have been made in delineating MS from other ADS subtypes over the past decade, including the discovery of serum aquaporin-4 (AQP4) and Myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). Both genetic (e.g. human leukocyte antigen, HLA-DRB1*1501 allele) and environmental risk factors (e.g. low serum vitamin D levels and prior exposure to Epstein–Barr virus) may contribute to risk of MS in children. Some of these risk factors not only confer increased susceptibility to MS but may also affect the disease course. Paediatric AQP4-Ab NMOSD is a rare disease worldwide but variations in incidence/prevalence have been described among different geographic regions and ethnicities. One-third of children who present with an ADS have MOG-Ab, and approximately half of patients with MOG-Ab have a relapsing disease course. It seems there is no racial or gender predominance in MOGAD, which is in contrast to the female and non-white predominance seen in both MS and NMOSD.‎ In this review, we examine the current literature regarding the epidemiology and demographics of these different ADS entities with a particular focus on the genetic and environmental risk factors for MS in children. While insights into disease pathophysiology in paediatric ADS have led recent therapeutic advances, well designed, collaborative large scale epidemiological studies are likely to provide the critical next step to a personalised approach to these conditions.

    2021引用:3
    引用
    AI阅读
    加入学术空间
    2Convulsive Status Epilepticus in Children in Mozambique: is There a Treatment Gap?
    Jo Marie. B. Sourbron,Lieven Lagae, Dalila Ibrahimo Sulemane

    Background: Optimal care of Convulsive status epilepticus (CSE) can be related to multiple barriers in resource-limited countries. Objectives and methods: Since limited data of CSE management are available from South-East Africa, we performed a retrospective analysis of the electronic records of pediatric patients with CSE admitted to the Maputo Central hospital from January 2016 until April 2019. Results: Our database consisted out of 39 patients. The average age was 5.15 (range 0.3-13.8) years and demographic characteristics did not show a relation to CSE characteristics or outcomes. However, the total stay in the hospital was negatively correlated with age (p=0.0314). Moreover, 14 patients needed to be admitted to the IC, which was correlated to having generalized motor seizures (p=0.0253), and a relatively higher need for a second AED to control their CSE (p=0.0131). Regarding AED use, the first AED was a IV benzodiazepine (BZD: midazolam (MIDA) or diazepam (DIAZ)) or IV phenytoin (PHEN) when BZDs were not available. There was no statistically significant difference between the efficacy of MIDA vs. DIAZ. Eleven patients received PHEN as a second-line drug, of which only two patients needed an additional dose of PHEN. None of the patients died and five patients (13.2%) had an extra comorbidity after CSE. Conclusions: Although limited AEDs were available in our study, compared to more AEDs in other developing and developed countries, we report the successful cessation of CSE in the majority of cases. We recommend strategies to improve prehospital management such as the use of non-IV BZD use, to limit the need for patients to be admitted to the IC and thereby potentially decreasing the number of AEDs, morbidity and hospital duration. Moreover, our data underline the conversion to second-line AEDs (PHEN) to be adequate in nearly all patients.

    2021
    引用
    AI阅读
    加入学术空间
    3Alpers- and MNGIE-like Disease with Disturbed CSF Folate Transport and an Unusual Mode of Genetic Transmission of POLG Mutations: a Case Report
    Rudolf Korinthenberg, Janbernd Kirschner,Matthias Eckenweiler,Robert Steinfeld,Nana Nino Tatishvili,Rita Horvath,Stephanie Kleinle,Angela Abicht

    We report about a family with three of five siblings affected by a variable remitting-relapsing disease with epileptic seizures, coma and abdominal crises, and lethal outcome in all. In the youngest son and in one of his deceased brothers we identified two disease causing compound heterozygous POLG mutations. One of these was inherited from the mother, but the other was absent in the father`s blood, saliva, buccal swab and hair bulbs although his paternity was proven genetically. Thus, we assume germline mosaicism for this mutation in the father. Very low 5-methyltetrahydrofolate (5-MTHF) and absence of folate receptor-alpha was repeatedly found in the CSF of the youngest brother indicating a secondary cerebral folate transport deficiency. Folinic acid supplementation over 18 months resulted in some improvement of the neurological condition; however, it did not prevent progression of the systemic disease.

    2021引用:1
    引用
    AI阅读
    加入学术空间
    4Rational Approach to Children with Drug-Resistant Epilepsy
    Elaine Wirrell

    Epilepsy is one of the most common neurological disorders to affect children, and has its highest incidence in infancy. Approximately one-quarter of children have seizures which are drug-resistant, and place the child at increased risk of cognitive delays, attention, behavior and psychiatric disorders, injury, sudden unexpected death and poor quality of life. This article presents a rational approach to the investigation and management of children with drug-resistant epilepsy.

    2021引用:1
    引用
    AI阅读
    加入学术空间
    5Dietary Therapies for Epilepsy in Low Resource Settings: Challenges and Successes
    Suvasini Sharma

    The Ketogenic Diet (KD) is a high fat, low carbohydrate and restricted protein diet which has been used for the treatment of drug resistant epilepsy in children. It is considered the treatment of choice for refractory nonsurgical epilepsy in children. However, despite this being a very useful and relatively simple treatment, children from developing countries have not been able to benefit as much as their counterparts in more privileged settings. In this article, the challenges faced by pediatric neurologists and parents who wish to use the diet in children with refractory epilepsy are discussed, and also the simple low cost innovations which can be used to overcome these challenges are suggested. The evolution from the use of the classic ketogenic diet to the flexible use of the modified Atkins diet in low resource settings will be discussed.

    2021
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 24 篇论文

    高被引作者

    作者引用发文
    Roberto Horacio Caraballo231
    Jannatara Shefa31
    Akhter Shaheen31
    Muzharul Mannan31
    Ori Hadad31
    Omar Abdel-Mannan31
    Yael Hacohen31
    Ine Hoogwijs21
    Haluk Topaloglu22
    Kirton C A11

    高产作者

    作者引用发文
    Haluk Topaloglu22
    Richard Idro12
    Jo M Wilmshurst12
    Pauline Samia12
    Silvia Tenembaum12
    Anaita Udwadia Hegde12
    Anna Jansen01
    Laura Silveira-Moriyama11
    Judith van Gaalen11
    Corry M. R. Weemaes11

    相关期刊

    Functional neurology
    Translational medicine @ UniSa
    Iranian journal of child neurology
    Journal of epilepsy research
    Open Neurology Journal
    Sinapse
    Journal of Neurology and Stroke
    Journal of the korean child neurology society
    Cerebellum and Ataxias
    Annals of Movement Disorders